MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/220/0.1/21.03.25 | Market Closed - Börse Stuttgart 12:13:50 2024-05-31 EDT | ||
| 0.129 EUR | +9.32% |
|
| Current month | -28.73% | ||
| 1 month | -28.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.129 | +9.32% |
| 24-05-30 | 0.118 | -0.84% |
| 24-05-29 | 0.119 | -5.56% |
| 24-05-28 | 0.126 | +12.50% |
| 24-05-27 | 0.112 | -18.84% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 12:13 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME9ZN2 |
| ISIN | DE000ME9ZN23 |
| Date issued | 2024-03-11 |
| Strike | 220 $ |
| Maturity | 2025-03-21 (293 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.35 € |
|---|---|
| Lowest since issue | 0.105 € |
| Delta | 0.09x |
| Omega | 8.155 |
| Premium | 63.71x |
| Gearing | 92.36x |
| Moneyness | 0.6149 |
| Difference Strike | 84.72 $ |
| Difference Strike % | +38.51% |
| Spread | 0.006 € |
| Spread % | 4.35% |
| Theoretical value | 0.1350 |
| Implied Volatility | 33.19 % |
| Total Loss Probability | 95.02 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1350 |
| Break even | 221.46 € |
| Theta | -0.01x |
| Vega | 0.02x |
| Rho | 0.01x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3
DKK
Average target price
917.2
DKK
Spread / Average Target
-1.09%
- Stock Market
- Warrants
- Warrant
